Copenhagen, Hovedstaden, Denmark The main department of described VC is located in the Copenhagen. The company was established in Europe in Denmark.
The usual cause for the fund is to invest in rounds with 6 partakers. Despite the Carnegie Asset Management, startups are often financed by MVI Finance, HBM Healthcare Investments AG, NGN Capital. The meaningful sponsors for the fund in investment in the same round are The Dow Chemical Company, NGN Capital, MVI Finance. In the next rounds fund is usually obtained by HBM Healthcare Investments AG, Biotech Turnaround Fund (BTF), YA Global Master SPV.
Besides them, we counted 5 critical employees of this fund in our database.
Moreover, a startup needs to be at the age of 4-5 years to get the investment from the fund. Among the most popular portfolio startups of the fund, we may highlight Genizon BioSciences, Santhera Pharmaceuticals, ZoomON. For fund there is no match between the country of its foundation and the country of its the most frequent investments - United States. We can highlight the next thriving fund investment areas, such as Business Development, Genetics.
Considering the real fund results, this VC is 3 percentage points less often commits exit comparing to other organizations. The common things for fund are deals in the range of 10 - 50 millions dollars. Opposing the other organizations, this Carnegie Asset Management works on 4 percentage points more the average amount of lead investments. The fund is generally included in less than 2 deals every year. The top activity for fund was in 2006. The increased amount of exits for fund were in 2007.
Related Funds
| Fund Name | Location |
| BAE Systems | Farnborough, Hampshire, United Kingdom |
| CFAO GROUP | Houston, Texas, United States |
| Clayton, Dubilier & Rice | New York, New York, United States |
| Fazer | Finland, Southern Finland, Vantaa |
| GX Software | Gelderland, Netherlands, Nijmegen |
| MP Pensjon | Norway, Oslo |
| NFQ Ventures | Canada, Ontario, Toronto |
| Nidus Center for Scientific Enterprise | Missouri, St Louis, United States |
| P&G Alumni China Network | - |
| Pride Capital Partners | Amsterdam, Noord-Holland, The Netherlands |
| Qujingshi Qilinqu Gongye Yuanqu Kaifa Touzi | China, Qujing, Yunnan |
| Renrendai | Beijing, China, Haidian |
| RSS Investors Fund | - |
| Select Venture Partners | Fredericksburg, United States, Virginia |
| SerComm | Taipei, Taiwan |
| Shanghai Bingye Qiye Guanlizhongxin | China, Shanghai |
| Tsingbay Venture Capital | China, Guangdong, Shenzhen |
| TuYoo Games | Beijing, Beijing, China |
| Yinlingdahang Touzi | China, Guangdong, Shenzhen |
Discover 4 more decision makers Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
Santhera Pharmaceuticals | $17M | 05 Oct 2006 | Basel-Country, Switzerland | ||
Santhera Pharmaceuticals | $18M | 20 Dec 2005 | Basel-Country, Switzerland | ||
Genizon BioSciences | $8M | 13 Dec 2004 | Montreal, Quebec, Canada | ||
Agensys | $42M | 04 Mar 2002 | Santa Monica, California, United States | ||
| $8M | 21 Jun 2000 | San Jose, California, United States |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
Santhera Pharmaceuticals | $17M | 05 Oct 2006 | Basel-Country, Switzerland | ||
Santhera Pharmaceuticals | $18M | 20 Dec 2005 | Basel-Country, Switzerland | ||
Genizon BioSciences | $8M | 13 Dec 2004 | Montreal, Quebec, Canada | ||
Agensys | $42M | 04 Mar 2002 | Santa Monica, California, United States | ||
| $8M | 21 Jun 2000 | San Jose, California, United States |
